In the latest trading session, Intuitive Surgical, Inc. (ISRG) closed at $383.42, marking a +0.28% move from the previous day. The stock's change was more than the S&P 500's daily gain of 0.11%. At the same time, the Dow lost 0.11%, and the tech-heavy Nasdaq gained 0.23%.The company's stock has dropped by 1.28% in the past month, exceeding the Medical sector's loss of 1.51% and lagging the S&P 500's gain of 1.5%.The investment community will be paying close attention to the earnings performance of Intuitive ...

If You Invested $5000 In Intuitive Surgical 10 Years Ago, This Is How Rich You Would Be Today VCG / Getty Images One of the time-tested investment methods is the “buy and hold strategy”. Popularized by investment guru Warren Buffett, this strategy attempts to take emotion out of market peaks and valleys, and relies on holding the stock while the fundamentals of the company’s finances, management, and business model all remain solid, so that the underlying value will be recognized. 24/7 Wall St. has tracke ...

Robotics Industry Overview - Robotics has the potential to transform industries like manufacturing and healthcare by creating new opportunities for automation and efficiency [1] - The rise of AI could drive robotics into a hyper-growth stage, offering long-term investment opportunities in cutting-edge technologies [1] Symbotic (SYM) - Symbotic is a leader in autonomous warehouse solutions, using AI to optimize storage, retrieval, and transportation of goods [2] - The company's revenue doubled consecutively since 2020, reaching $1.2 billion in 2023, a 98% year-over-year increase [2] - Symbotic operates in the $20 billion SCM software industry, with significant growth potential in retail-focused solutions [3] Intuitive Surgical (ISRG) - Intuitive Surgical is a pioneer in robotic-assisted surgery, with its da Vinci Surgical System used in over 13 million surgeries across various specialties [4][5] - The company reported strong Q4 2023 earnings, beating Wall Street estimates, with shares surging 10% post-earnings and rising 18% year-to-date [5] UiPath (PATH) - UiPath specializes in robotic process automation (RPA) and AI, enabling businesses to automate repetitive tasks across industries like banking, healthcare, and manufacturing [6] - Despite a 7% YTD share price decline, the company reported a 31% YOY increase in Q4 2023 revenue to $405 million and achieved its first GAAP profitable quarter [7]

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider Intuitive Surgical, Inc. (ISRG) . This company, which is in the Zacks Medical - Instruments industry, shows potential for another earnings beat.When looking at the last two reports, this company has recorded a strong streak of surpassing earnings estimates. The company has topped estimates by 6.19%, on average, in the last two ...

The U.S. economy is on a positive trajectory, fueled by robust consumer spending and business investments. With profits rising steadily, there’s an encouraging trend of retaining employees, further supporting economic expansion. This market confidence will only contribute to the growth of innovation. And right now the best bet on the future is finding robotics stocks to buy. Projections indicate that the global business process automation market will expand at a CAGR of 11.4% until 2030. As businesses adapt ...

Intuitive Surgical (ISRG -0.25%) is a healthcare company with the potential to help transform an industry with its robotic-assisted surgical systems. By making surgeries easier and more precise for surgeons, they can improve outcomes for patients and help drive efficiency in the industry as well.The company has experienced incredible growth over the years, and it has the potential to become much larger and more valuable in the future. But is there enough upside here for this stock to be a millionaire-making ...

Over the past five years, Intuitive Surgical (ISRG -0.04%) has gone through numerous trials and tribulations. The pandemic significantly disrupted its operations, initially leading to worse financial results than hoped. Various economic issues, including supply chain problems, have also affected Intuitive Surgical in the past half a decade. Still, the medical device specialist has delivered solid returns during this period.Though Intuitive Surgical still has some challenges to deal with (more on that later) ...

When seeking out potential investments, focusing on growth stocks can be a lucrative strategy for investors. Innovative companies with solid growth prospects often outperform the market, as represented by the S&P 500 index. While such companies typically come with a premium price tag, the allure of multibagger gains makes growth stocks attractive for many long-term investors. For instance, the Vanguard Growth ETF (NYSEARCA:VUG), an exchange-traded fund (ETF) giving exposure to large-cap U.S. growth stocks, ...

Stock Performance - Intuitive Surgical Inc (ISRG) closed at $390 53, marking a -0 53% move from the previous day, underperforming the S&P 500 which gained 0 57%, the Dow which added 0 83%, and the Nasdaq which gained 0 39% [1] - Over the past month, ISRG shares appreciated by 3 69%, outperforming the Medical sector's gain of 0 13% and the S&P 500's gain of 2 97% [1] Earnings and Revenue Expectations - The company is anticipated to report an EPS of $1 39 in its forthcoming earnings report, a 13 01% rise compared to the same quarter of the previous year [1] - Revenue is expected to be $1 87 billion, indicating a 10 09% increase compared to the same quarter of the previous year [1] - For the full year, analysts expect earnings of $6 18 per share and revenue of $7 98 billion, marking changes of +8 23% and +11 95% respectively from last year [2] Analyst Estimates and Revisions - Recent changes to analyst estimates for ISRG reflect evolving short-term business trends, with positive estimate revisions indicating optimism about the company's business outlook [2] - The Zacks Consensus EPS estimate remained stagnant within the past month, and ISRG currently has a Zacks Rank of 4 (Sell) [3] Valuation Metrics - ISRG has a Forward P/E ratio of 63 52, representing a premium compared to its industry's average Forward P/E of 27 [3] - The company's PEG ratio is 4 87, significantly higher than the Medical - Instruments industry average PEG ratio of 2 31 [3] Industry Overview - The Medical - Instruments industry, part of the Medical sector, has a Zacks Industry Rank of 70, placing it in the top 28% of all industries [4] - The Zacks Industry Rank shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [4]

Intuitive Surgical's flagship da Vinci system 3alexd/E+ via Getty Images Intuitive Surgical, Inc. (NASDAQ:ISRG) has been on a tear over the last 12 months, up 61% since March last year. Revenues rebounded in 2023 to $7.1bn with 14% YoY growth, driven by a 21% increase in procedure volume of their flagship da Vinci system. The company is also in an excellent financial position with $5.2bn in cash and zero debt. However, with a P/E of 78.8 and an EV/EBITDA of 62.4 it may be looking expensive, and there are ...